>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

October 13, 2014

FDA MedWatch - ICU Medical ConMed Stat2 Flow Controller: Class 1 Recall - Delivers Higher Flow Rate than Intended

Summary:

FDA MedWatch ICU Medical ConMed Stat2 Flow Controller

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Information on Meningitis Multi-State Outbreak

Friday, October 05, 2012

UPDATED:  As you may be aware, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are currently investigating a recent outbreak of fungal meningitis among patients who received an epidural steroid injection after May 21, 2012.  Seven deaths have been reported as of October 7, 2012.  Our thoughts and prayers are with the patients and their families affected by this horrific tragedy.

It is important to remind patients:

  • Steroid injections are safe.
  • These cases are associated with a potentially contaminated batch of medication.
  • Investigation into the exact source of the contamination is ongoing; however, interim data show that all infected patients received injection with preservative-free methylprednisolone acetate (80mg/ml) prepared by New England Compounding Center (NECC), located in Framingham, Mass.
  • As of Oct. 3, 2012, NECC has voluntarily shut down.
  • As of Oct. 7, 2012, NECC has voluntarily recalled all of its products. 
  • Fungal meningitis is not transmitted from person to person.

If patients have questions or concerns, they should contact their immediate health care provider.

FDA and CDC recommend that healthcare professionals cease use of any product produced by the NECC until further information is available.  NECC has recall of its products.

For more information concerning the recalled lots, or to read the full statements, including recommendations, from FDA and CDC, access the resources below:

 

« Back to Washington Alerts